You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 15, April 16, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Perspectives on Care at the Close of Life: CODA
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Patient-Physician Relationship/ Care
 •End-of-life Care/ Palliative Medicine
 •Perspectives on Care at the Close of Life
 •Gastroenterology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Management of Intractable Nausea and Vomiting in Patients at the End of Life

"I Was Feeling Nauseous All of the Time . . . Nothing Was Working"

Amy J. Markowitz, JD; Michael W. Rabow, MD

JAMA. 2008;299(15):1826.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

On September 12, 2007, Wood et al1 presented the case of Mr Q, a 50-year-old man with metastatic esophageal cancer who was admitted to a university hospital through the emergency department with intractable nausea and vomiting. Nausea and vomiting represent a substantial source of physical and psychological distress for patients and families. The authors reviewed the evaluation and treatment of this symptom complex, observing that a thorough history and physical examination are essential because they provide a measure of the severity of the symptoms and clues to their underlying etiology. Once the most likely etiology is determined, the clinician must discern the mechanism, specific transmitters, and receptors by which this etiology is triggering the symptoms. Subsequent pharmacological management focuses on prescribing the appropriate antagonist to the implicated receptors. If symptoms are refractory despite adequate dosage and around-the-clock prophylactic administration, an empirical trial . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.